Multiple Sclerosis (MS) is a progressive and chronic disease that attacks the central nervous system. It occurs when the body’s own immune system attack the protective sheath (myelin) around the nerve fibres (axons) in the brain and spinal cord, resulting in random patches called plaques or lesions. These in turn distort and interrupt their ability to conduct signals. The disease derives its name from ‘Sclerosis’ meaning scars and ‘multiple’ because the damage usually occurs across a number of points.
More than 2.5 million people around the world are said to be affected by multiple sclerosis. Disease onset is usually seen more in young adults, and it is more common in women. Almost 98% of the MS population is Caucasian. MS is generally more common in people living in temperate zones.
To find out more about this disease, please download the whitepaper here >
The World Orphan Drug Congress team is delighted to welcome Genpharm as a sponsor to the 2013 event, taking place in November! Find out more about this event here